<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00850025525619</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WGM35135CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T05:08:44.407Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525602</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WGM35090CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T05:03:00.235Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525596</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WGM35065CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T04:55:46.786Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525589</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WGM18150CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T04:49:02.967Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525572</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WGM18135CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T04:41:33.841Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525565</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WGM18090CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T04:32:52.380Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525558</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WGM14150CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T04:25:21.619Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525541</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WGM14135CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T04:15:35.779Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525534</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WGM14065CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T03:53:11.667Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525527</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WMC14150CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T03:33:11.016Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525510</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WMC14135CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:46:56.607Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850025525503</udiDi>
    <basicUdiDi>856492005SupportCathKP</basicUdiDi>
    <tradeName>Wingman</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Reflow Medical, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017521</manufacturerSrn>
    <authorisedRepresentativeName>MediMark Europe Sarl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000000182</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WMC14090CE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T09:18:40.811Z</lastUpdated>
  </row>
  <row>
    <udiDi>00860009199705</udiDi>
    <basicUdiDi>08600091997PER2R8</basicUdiDi>
    <tradeName>Santreva-ATK</tradeName>
    <deviceName>Santreva-ATK Endovascular Revascularization Catheter</deviceName>
    <manufacturerName>Angiosafe Inc</manufacturerName>
    <manufacturerSrn>US-MF-000047926</manufacturerSrn>
    <authorisedRepresentativeName>OMC NI MEDICAL LIMITED</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>XI-AR-000019483</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020209</emdnCode>
    <emdnDescription>PERIPHERAL VASCULAR SYSTEM TOTAL CHRONIC OCCLUSION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AS-1963-02</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T03:52:51.158Z</lastUpdated>
  </row>
</eudamedExport>